Page last updated: 2024-09-05

bd 1047 and bms 387032

bd 1047 has been researched along with bms 387032 in 1 studies

Compound Research Comparison

Studies
(bd 1047)
Trials
(bd 1047)
Recent Studies (post-2010)
(bd 1047)
Studies
(bms 387032)
Trials
(bms 387032)
Recent Studies (post-2010) (bms 387032)
11805476356

Protein Interaction Comparison

ProteinTaxonomybd 1047 (IC50)bms 387032 (IC50)
Cyclin-T1Homo sapiens (human)0.0103
G2/mitotic-specific cyclin-B2Homo sapiens (human)0.48
G1/S-specific cyclin-E2Homo sapiens (human)0.048
Vitamin K-dependent protein CHomo sapiens (human)0.264
Cyclin-dependent kinase 1Homo sapiens (human)0.48
Cyclin-dependent kinase 4Homo sapiens (human)0.7538
G2/mitotic-specific cyclin-B1Homo sapiens (human)0.48
Cyclin-A2Homo sapiens (human)0.0427
G1/S-specific cyclin-D1Homo sapiens (human)0.925
G1/S-specific cyclin-E1Homo sapiens (human)0.046
Cyclin-dependent kinase 2Homo sapiens (human)0.0426
G1/S-specific cyclin-D2Homo sapiens (human)0.925
G1/S-specific cyclin-D3Homo sapiens (human)0.925
Cannabinoid receptor 2Mus musculus (house mouse)0.062
Cyclin-dependent kinase 7Homo sapiens (human)0.0772
Cyclin-dependent kinase 9Homo sapiens (human)0.1078
Cyclin-HHomo sapiens (human)0.0823
CDK-activating kinase assembly factor MAT1Homo sapiens (human)0.1027
Cyclin-A1Homo sapiens (human)0.021
Cyclin-dependent-like kinase 5 Homo sapiens (human)0.34
Cyclin-dependent kinase 5 activator 1Homo sapiens (human)0.34
G2/mitotic-specific cyclin-B3Homo sapiens (human)0.48

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ1

Other Studies

1 other study(ies) available for bd 1047 and bms 387032

ArticleYear
Identification of potent Yes1 kinase inhibitors using a library screening approach.
    Bioorganic & medicinal chemistry letters, 2013, Aug-01, Volume: 23, Issue:15

    Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship

2013